(Q32020860)

5 July 2017

title

Cocaine catalytic antibodies: the primary importance of linker effects (English)

1 reference

5 July 2017

1 reference

ChEBI release 2020-05-28

1 reference

Matsushita M

1

1 reference

5 July 2017

Hoffman TZ

2

1 reference

5 July 2017

Ashley JA

3

1 reference

5 July 2017

Zhou B

4

1 reference

5 July 2017

Wirsching P

5

1 reference

5 July 2017

Janda KD

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

5 July 2017

published in

1 reference

5 July 2017

volume

11

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

87-90

1 reference

Cocaine abuse in North America: a milestone in history

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

AIDS and i.v. drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Cocaine vaccines: antibody protection against relapse in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Suppression of psychoactive effects of cocaine by active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Efficacy of a therapeutic cocaine vaccine in rodent models.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

1 reference

7 January 2021

From molecular diversity to catalysis: lessons from the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Estimation and disposition of [3H]benzoylecgonine and pharmacological activity of some cocaine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Antibody-catalyzed degradation of cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Prediction of stability in pharmaceutical preparations XX: stability evaluation and bioanalysis of cocaine and benzoylecgonine by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

In vivo and in vitro studies on cocaine metabolism: ecgonine methyl ester as a major metabolite of cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Human antibodies from combinatorial libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

Reactive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900659-4

7 January 2021

10.1016/S0960-894X(00)00659-4

Identifiers

DOI

1 reference

5 July 2017

1 reference